|
|
|||||||
Case Reports |
We report the successful use of bortezomib to treat a patient with multiple myeloma (MM) who had extramedullary relapse (paraspinal and thoracic masses and multiple cranial nerve palsy) after autologous and non-myeloablative allogeneic hematopoietic stem cell transplantation (HSCT).
This article has been cited by other articles:
![]() |
P Raanani, O Shpilberg, and I Ben-Bassat Extramedullary disease and targeted therapies for hematological malignancies--is the association real? Ann. Onc., January 1, 2007; 18(1): 7 - 12. [Abstract] [Full Text] [PDF] |
||||
![]() |
K.-S. Eom, C.-K. Min, S. Lee, Y.-J. Kim, S.-Y. Kim, H.-J. Kim, J.-W. Lee, W.-S. Min, and C.-C. Kim Efficacy of Up-Front Treatment with a Double Stem Cell Transplantation in Multiple Myeloma Jpn. J. Clin. Oncol., July 1, 2006; 36(7): 432 - 438. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | TABLE OF CONTENTS | ARCHIVE | SUBSCRIPTIONS |